Leonard Frank X Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
33
Insider Sells Sum
$8.75M

Insider Activity of Leonard Frank X

According to the SEC Form 4 filings, Leonard Frank X, being in a position of

  1. Chief Executive Officer at Novocure Ltd,
    оver the last 12 months, has bought 0 shares, and sold 56846 shares for $919,823,
    over all time since 2021-03-02, has bought 0 shares, and sold 206862 shares for $10.2M.

Biography of Leonard Frank X

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $919,8234100

Comparison of Insiders on Amount of Buys and Sells

2026-06-04SaleNovoCure Limited
NVCR
Chief Executive Officer
34,273
0.0295%
$17.93$614,635-10.56%
2026-03-04SaleNovoCure Limited
NVCR
Chief Executive Officer
5,607
0.005%
$13.31$74,603+18.03%
2026-03-02SaleNovoCure Limited
NVCR
Chief Executive Officer
7,232
0.0064%
$13.49$97,581+17.09%
2026-02-27SaleNovoCure Limited
NVCR
Chief Executive Officer
9,734
0.0087%
$13.66$133,003+15.76%
2025-06-02SaleNovoCure Limited
NVCR
EVP, Pres., Novocure Oncology
30,196
0.0278%
$17.50$528,413-24.65%
2025-03-03SaleNovoCure Limited
NVCR
EVP, Pres., Novocure Oncology
2,527
0.0024%
$18.54$46,841-25.8%
2025-02-28SaleNovoCure Limited
NVCR
EVP, Pres., Novocure Oncology
2,770
0.0025%
$18.28$50,648-28.11%
2025-02-27SaleNovoCure Limited
NVCR
EVP, Pres., Novocure Oncology
12,266
0.0117%
$20.02$245,609-28.5%
2024-11-01SaleNovoCure Limited
NVCR
EVP, Pres., Novocure Oncology
598
0.0005%
$15.94$9,531+8.71%
2024-03-04SaleNovoCure Limited
NVCR
EVP, Pres., Novocure Oncology
840
0.0008%
$16.01$13,448+9.83%
2024-03-01SaleNovoCure Limited
NVCR
EVP, Pres., Novocure Oncology
1,679
0.0015%
$16.03$26,909+10.89%
2024-02-28SaleNovoCure Limited
NVCR
EVP, Pres., Novocure Oncology
2,078
0.002%
$16.14$33,545+12.48%
2023-03-07SaleNovoCure Limited
NVCR
President, CNS Cancers US
8,318
0.0079%
$75.16$625,205-73.1%
2023-03-03SaleNovoCure Limited
NVCR
President, CNS Cancers US
5,291
0.0049%
$76.16$402,959-73.06%
2023-03-03SaleNovoCure Limited
NVCR
President, CNS Cancers US
7,350
0.0068%
$76.57$562,818-73.06%
2023-03-03SaleNovoCure Limited
NVCR
President, CNS Cancers US
2,059
0.0019%
$77.64$159,859-73.06%
2023-03-02SaleNovoCure Limited
NVCR
President, CNS Cancers US
844
0.0008%
$75.28$63,535-71.48%
2023-03-02SaleNovoCure Limited
NVCR
President, CNS Cancers US
4,951
0.0047%
$75.36$373,112-71.48%
2023-03-01SaleNovoCure Limited
NVCR
President, CNS Cancers US
1,684
0.0016%
$76.36$128,594-71.58%
2023-01-05SaleNovoCure Limited
NVCR
President, CNS Cancers US
10,471
0.0099%
$119.05$1.25M-65.88%
Total: 38
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.